Gastrointestinal Therapeutics Market Foreseen To Increase Exponentially By 2030
Gastrointestinal Therapeutics Industry The global gastrointestinal therapeutics market size is expected to reach USD 48.61 billion by 2030, advancing at a CAGR of 3.3% during the forecast period, as per a new report by Grand View Research, Inc. Unhealthy eating habits, coupled with a sedentary lifestyle, have led to the development of gastrointestinal diseases among consumers, which is expected to drive market growth. Moreover, the rising adoption of biologics for the treatment of GI disorders is also fueling growth. For instance, REMICADE (Infliximab) by Janssen Biotech, Inc., and other biological drugs have been approved for the treatment of Crohn’s disease and ulcerative colitis. The increasing incidences of industry-academia collaborations to promote gastrointestinal research and develop novel therapies for patients with GI disorders will likely facilitate market expansion. For instance, in November 2020, Takeda Pharmaceutical Company Limited, Colum...